Contraception
Volume 80, Issue 6 , Pages 540-554 , December 2009

The EVAPIL® scale, a new tool to assess tolerance of oral contraceptives

  • Olivier Graesslin

      Affiliations

    • Centre Hospitalier Universitaire, Institut Mère Enfant Alix de Champagne, Service de Gynécologie-Obstétrique, F-51092 Reims, France
    • Corresponding Author InformationCorresponding author. Tel.: +33 3 26 78 35 17; fax: +33 3 26 78 38 39.
    • ,
  • Philippe Barjot

      Affiliations

    • Service de Gynécologie-Obstétrique, Polyclinique du Parc, F-14052 Caen cedex 04, France
    • ,
  • Médéric Hoffet

      Affiliations

    • Service de Gynécologie-Obstétrique, CHU Carremeau, place du Professeur Robert Debré, F-30029 Nîmes cedex 09, France
    • ,
  • Daniel Cohen

      Affiliations

    • Service de Gynécologie-Obstétrique, Centre Hospitalier du Pays d'Aix, F-13616 Aix-en-Provence cedex 01, France
    • ,
  • Philippe Vaillant

      Affiliations

    • Service de Gynécologie-Obstétrique, Centre Hospitalier Laënnec, F-60109 Creil cedex, France
    • ,
  • Pierre Clerson

      Affiliations

    • Orgamétrie Biostatistiques, F-59100 Roubaix, France

Received 25 May 2008 ,Revised 15 April 2009 ,Accepted 5 June 2009.

References 

  1. Laveissière MN, Pelissier C, Lé M. Oral contraception in France in 2001: results of an opinion survey conducted in 3609 women between 15 and 45 years old. Gynecol Obstet Fertil. 2003;31:220–229
  2. Serfaty D, Vree ML. A comparison of the cycle control and tolerability of two ultra low-doses oral contraceptives containing 20 micrograms ethynilestradiol and either 150 micrograms desogestrel or 75 micrograms gestodene. Eur J Contracept Reprod Health Care. 1998;3:179–189
  3. Rosenberg MJ, Waugh MS, Burnhill MS. Compliance, counseling and satisfaction with oral contraceptives: a prospective evaluation. Fam Plann Perspect. 1998;30(8-92):104
  4. Rosenberg MJ, Waugh MS, Meehan TE. Use and misuse of oral contraceptives: risk indicators for poor pill-taking and discontinuation. Contraception. 1995;51:283–288
  5. Belsey EM, Carlson N. The description of menstrual bleeding patterns: towards fewer measures. Stat Med. 1991;10:267–284
  6. Anderson FD, Hait H, multicenter A. randomized study of an extended cycle oral contraceptive. Contraception. 2003;68:89–96
  7. Mishell DR, Guillebaud J, Westhoff C, et al. Combined hormonal contraceptive trials: variable data collection and bleeding assessment methodologies influence study outcomes and physician perception. Contraception. 2007;76:4–10
  8. Belsey EM, Machin D, d'Arcangues D. The analysis of vaginal bleeding patterns induced by fertility regulating methods. World Health Organization Special Programme of Research, Development and Research Training in Human Reproduction. Contraception. 1986;34:253–260
  9. Mishell DR, Guillebaud J, Westhoff C, et al. Recommendations for standardization of data collection and analysis of bleeding in combined hormone contraceptive trials. Contraception. 2007;75:11–15
  10. Moreau C, Trussell J, gilbert F, Bajos N, Bouyer J. Oral contraceptive tolerance: does the type of pill matter?. Obstet Gynecol. 2007;109:1277–1285
  11. Archer DF, Maheux R, DelConte A, O'Brien FB. Efficacy and safety of a low-dose monophasic combination oral contraceptive containing 100 microg levonorgestrel and 20 microg ethinyl estradiol (Alesse). North American Levonorgestrel Study Group (NALSG). Am J Obstet Gynecol. 1999;181(5 Pt 2):39–44
  12. Audet MC, Moreau MM, Koltun WD, et al. Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs an oral contraceptive: a randomized controlled trial. JAMA. 2001;285:2347–2354

PII: S0010-7824(09)00307-2

doi: 10.1016/j.contraception.2009.06.008

Contraception
Volume 80, Issue 6 , Pages 540-554 , December 2009

Article Tools

* Image Usage & Resolution